Ira Winer
Clinical trials sponsored by Ira Winer, explained in plain language.
-
New hope for Hard-to-Treat ovarian cancer: drug combo shows promise
Disease control Recruiting nowThis study tests a new drug called ONC201 combined with the chemotherapy paclitaxel in people with ovarian, fallopian tube, or peritoneal cancer that has stopped responding to platinum-based treatments. The goal is to see if the combination is safe and works better than paclitaxe…
Phase: PHASE2 • Sponsor: Ira Winer • Aim: Disease control
Last updated Jun 18, 2026 11:52 UTC
-
Question list may empower gynecologic cancer patients in clinic
Knowledge-focused Recruiting nowThis study tests whether giving gynecologic cancer patients a list of questions to ask their doctor improves their confidence, reduces distress, and builds trust. About 70 adults with newly diagnosed or suspected gynecologic cancer will either receive the question list or usual c…
Phase: NA • Sponsor: Ira Winer • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:48 UTC